☰

Niannian Ji, Ph.D. - Publications

Affiliations: 
2010 Biology The University of Texas at San Antonio, San Antonio, TX, United States 
Area:
Immunology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

13/24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Ji N, Mukherjee N, Shu ZJ, Reyes RM, Meeks JJ, McConkey DJ, Gelfond JA, Curiel TJ, Svatek RS. γδ T cells support antigen-specific αβ T cell-mediated antitumor responses during BCG treatment for bladder cancer. Cancer Immunology Research. PMID 34607803 DOI: 10.1158/2326-6066.CIR-21-0285  0.376
2021 Chase Huizar C, Ji N, Reddick R, Ostroff GR, Forsthuber TG. Glucan particles as a novel adjuvant for the induction of experimental autoimmune encephalomyelitis. Cellular Immunology. 366: 104383. PMID 34111646 DOI: 10.1016/j.cellimm.2021.104383  0.608
2019 Ji N, Mukherjee N, Morales EE, Tomasini ME, Hurez V, Curiel TJ, Abate G, Hoft DF, Zhao XR, Gelfond J, Maiti S, Cooper LJN, Svatek RS. Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial. Oncoimmunology. 8: 1614857. PMID 31413921 DOI: 10.1080/2162402X.2019.1614857  0.355
2018 Nalawade SA, Ji N, Raphael I, Pratt A, Kraig E, Forsthuber TG. Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4. Cellular Immunology. PMID 29789121 DOI: 10.1016/J.Cellimm.2018.05.003  0.64
2016 Ji N, Forsthuber TG. ELISPOT Techniques. Methods in Molecular Biology (Clifton, N.J.). 1304: 63-71. PMID 25117217 DOI: 10.1007/7651_2014_111  0.59
2015 Ji N, Kovalovsky A, Fingerle-Rowson G, Guentzel MN, Forsthuber TG. Macrophage migration inhibitory factor promotes resistance to glucocorticoid treatment in EAE. Neurology® Neuroimmunology & Neuroinflammation. 2: e139. PMID 26280015 DOI: 10.1212/Nxi.0000000000000139  0.6
2015 Latham LB, Lee MJ, Lincoln JA, Ji N, Forsthuber TG, Lindsey JW. Antivirus immune activity in multiple sclerosis correlates with MRI activity. Acta Neurologica Scandinavica. PMID 25939660 DOI: 10.1111/ane.12417  0.565
2014 Shetty A, Gupta SG, Varrin-Doyer M, Weber MS, Prod'homme T, Molnarfi N, Ji N, Nelson PA, Patarroyo JC, Schulze-Topphoff U, Fogal SE, Forsthuber T, Sobel RA, Bernard CC, Slavin AJ, et al. Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE. Neurology® Neuroimmunology & Neuroinflammation. 1: e22. PMID 25340074 DOI: 10.1212/Nxi.0000000000000022  0.661
2013 Sosa RA, Murphey C, Ji N, Cardona AE, Forsthuber TG. The kinetics of myelin antigen uptake by myeloid cells in the central nervous system during experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 191: 5848-57. PMID 24227784 DOI: 10.4049/Jimmunol.1300771  0.613
2013 Ji N, Somanaboeina A, Dixit A, Kawamura K, Hayward NJ, Self C, Olson GL, Forsthuber TG. Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis. Journal of Immunology (Baltimore, Md. : 1950). 191: 5074-84. PMID 24123687 DOI: 10.4049/Jimmunol.1300407  0.656
2011 Ji N, Sosa RA, Forsthuber TG. More than just a T-box: the role of T-bet as a possible biomarker and therapeutic target in autoimmune diseases. Immunotherapy. 3: 435-41. PMID 21395384 DOI: 10.2217/Imt.10.111  0.693
2011 Ji N, Rao N, Guentzel NM, Arulanandam BP, Forsthuber TG. Anaphylaxis and mortality induced by treatment of mice with anti-VLA-4 antibody and pertussis toxin. Journal of Immunology (Baltimore, Md. : 1950). 186: 2750-6. PMID 21270409 DOI: 10.4049/Jimmunol.1000907  0.638
2007 Forsthuber TG, Ji N. Quo vadis Th1 and Th2 cells in autoimmunity and infectious diseases: Th17 cells, the new kid on the block. Expert Review of Clinical Immunology. 3: 251-4. PMID 20477666 DOI: 10.1586/1744666X.3.3.251  0.612
Low-probability matches (unlikely to be authored by this person)
2018 Svatek RS, Ji N, de Leon EMB, Mukherjee N, Kabra A, Hurez V, Nicolas M, Michalek JE, Javors M, Wheeler K, Sharp ZD, Livi CB, Shu ZJ, Henkes DN, Curiel TJ. Rapamycin prevents surgery-induced immune dysfunction in patients with bladder cancer. Cancer Immunology Research. PMID 30563829 DOI: 10.1158/2326-6066.Cir-18-0336  0.286
2021 Reyes RM, Deng Y, Zhang D, Ji N, Mukherjee N, Wheeler K, Gupta HB, Padron AS, Kancharla A, Zhang C, Garcia M, Kornepati AVR, Boyman O, Conejo-Garcia JR, Svatek RS, et al. CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation. Journal For Immunotherapy of Cancer. 9. PMID 33849925 DOI: 10.1136/jitc-2020-002051  0.228
2021 Reyes RM, Zhang C, Deng Y, Ji N, Mukherjee N, Padron AS, Clark CA, Svatek RS, Curiel TJ. CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation. Oncoimmunology. 10: 2006529. PMID 34858732 DOI: 10.1080/2162402X.2021.2006529  0.226
2021 Ji N, Mukherjee N, Reyes RM, Gelfond J, Javors M, Meeks JJ, McConkey DJ, Shu ZJ, Ramamurthy C, Dennett R, Curiel TJ, Svatek RS. Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study. Journal For Immunotherapy of Cancer. 9. PMID 33653802 DOI: 10.1136/jitc-2020-001941  0.216
2021 Mukherjee N, Ji N, Xi T, Lin CL, Rios E, Chen CL, Huang T, Svatek RS. Bladder tumor ILC1s undergo Th17-like differentiation in human bladder cancer. Cancer Medicine. PMID 34496133 DOI: 10.1002/cam4.4243  0.19
2018 Mukherjee N, Ji N, Hurez V, Curiel TJ, Montgomery MO, Braun AJ, Nicolas M, Aguilera M, Kaushik D, Liu Q, Ruan J, Kendrick KA, Svatek RS. Intratumoral CD56 natural killer cells are associated with improved survival in bladder cancer. Oncotarget. 9: 36492-36502. PMID 30559932 DOI: 10.18632/Oncotarget.26362  0.179
2022 Mukherjee N, Ji N, Tan X, Chen CL, Noel ODV, Rodriguez-Padron M, Lin CL, Alonzo DG, Huang TH, Svatek RS. KLRF1, a novel marker of CD56 NK cells, predicts improved survival for patients with locally advanced bladder cancer. Cancer Medicine. PMID 36583228 DOI: 10.1002/cam4.5579  0.17
2022 Ji N, Long M, Garcia-Vilanova A, Ault R, Moliva JI, Yusoof KA, Mukherjee N, Curiel TJ, Dixon H, Torrelles JB, Svatek RS. Selective delipidation of Mycobacterium bovis BCG retains antitumor efficacy against non-muscle invasive bladder cancer. Cancer Immunology, Immunotherapy : Cii. PMID 35748904 DOI: 10.1007/s00262-022-03236-y  0.081
2019 Wheeler* K, Mukherjee N, Ji N, Svatek R. MP57-06 SURGICALLY-INDUCED STRESS ALTERS TUMOR SURVIVAL AND RESPONSE TO ADJUVANT IMMUNOTHERAPY IN BLADDER CANCER Journal of Urology. 201. DOI: 10.1097/01.JU.0000556629.03891.53  0.053
2021 Kaushik D, Shah PK, Mukherjee N, Ji N, Dursun F, Kumar AP, Thompson IM, Mansour AM, Jha R, Yang X, Wang H, Darby N, Ricardo Rivero J, Svatek RS, Liss MA. Effects of yoga in men with prostate cancer on quality of life and immune response: a pilot randomized controlled trial. Prostate Cancer and Prostatic Diseases. PMID 34815548 DOI: 10.1038/s41391-021-00470-w  0.042
2004 Ji N, Peng B, Wang G, Wang S, Peng X. Universal primer PCR with DGGE for rapid detection of bacterial pathogens. Journal of Microbiological Methods. 57: 409-13. PMID 15134888 DOI: 10.1016/j.mimet.2004.02.010  0.039
Hide low-probability matches.